Related Experiment Videos
Advanced bladder cancer: options of therapy
1Department of Urology, Wayne State University, School of Medicine, Detroit, MI 48201.
Cancer Chemotherapy and Pharmacology
|January 1, 1994
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis.
Molecular urology·2002
Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
The Journal of urology·2001
Salvage radical prostatectomy.
The Urologic clinics of North America·2001
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.
Cancer chemotherapy and pharmacology·2026
Pharmacological inhibition of store-operated calcium entry enhances sorafenib-induced antitumor effects in Huh7 hepatocellular carcinoma cells.
Cancer chemotherapy and pharmacology·2026
Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.
Cancer chemotherapy and pharmacology·2026
Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review.
Cancer chemotherapy and pharmacology·2026
First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.
Expert review of pharmacoeconomics & outcomes research·2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.
International journal of urology : official journal of the Japanese Urological Association·2026
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.
Neuro-oncology advances·2026